O'Neill Gilmore Neil plan to sell securities of Editas Medicine, Inc. under Form 144

O'Neill Gilmore Neil filed Form 144 to notify SEC of plan to sell 15000 units of Editas Medicine, Inc. securities around 2026-06-03, with aggregate market value of $46,200.00. The total outstanding units is 97906282.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 months include: On 03/03/2026, sold 5394 units for $10894.26;